Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Recs

0
Player Avatar chk999 (99.97) Submitted: 7/23/2007 12:25:53 PM : Underperform Start Price: $15.58 OMPI Score: +21.08

Purely a momentum play. This is very down
on a day the market is climbing.

Featured Broker Partners


Advertisement